Sign in Subscribe
Workers

COVID-19 Vaccination Durability and Breakthrough Infections in Healthcare Workers

Strategic Insights

— 1 min read

Researchers at the University of California conducted a small cohort study to assess the durability of COVID-19 vaccine-induced immunity in healthcare workers (HCWs) and its impact on breakthrough infections. The study found that antibody levels declined significantly over time, particularly in participants without prior infection, and that eight of nine breakthrough infections occurred after the third vaccine dose during the Omicron-dominant period.

Key Takeaways:

  • The study assessed antibody levels and breakthrough infection rates in 32 HCWs over 12 months post-vaccination, providing insights for booster strategies and infection control.
  • Nine participants showed breakthrough infections, with nucleocapsid antibodies indicating prior infection, and eight of these cases occurred after the third vaccine dose during the Omicron-dominant period.
  • Anti-spike antibody levels declined significantly in participants without prior infection, while those with breakthrough infections exhibited increased levels.
  • The half-life of S1 and S1 receptor-binding domain (RDB) vaccine-induced antibodies was 144 and 166 days, respectively, aligning with CDC data.
  • The study highlights the waning antibody levels over time and the occurrence of breakthrough infections, supporting the need for ongoing monitoring and timely boosters.

Statistics:

  • 32 HCWs were screened for SARS-CoV-2 infection using weekly self-administered swabs and blood samples collected at baseline, 6 months, and 12 months.
  • Nine participants showed breakthrough infections, with eight occurring after the third vaccine dose during the Omicron-dominant period.
  • 144 days: the half-life of S1 vaccine-induced antibodies.
  • 166 days: the half-life of S1 receptor-binding domain (RDB) vaccine-induced antibodies.

Sources:

  • NewsRx. New COVID-19 Findings from University of California Published (Insights Gained from the Immune Response and Screening of Healthcare Workers After COVID-19 Vaccination). Medical Letter on the CDC & FDA. September 14, 2025; p 127.
  • Insights Gained from the Immune Response and Screening of Healthcare Workers After COVID-19 Vaccination. COVID, 2025,5(8):129.

Read more